Tag: Hatch-Waxman Act
Patent Litigation: How Authorized Generics Undermine Generic Drug Competition
Authorized generics let brand-name drug makers launch their own cheap versions during the first generic’s exclusivity period, crushing real competition and keeping prices high. Here’s how it works-and why it’s hurting patients.